A recent study published in Progress in Neuropsychopharmacology & Biological Psychiatry suggests that cannabidiol (commonly ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

"We are also pleased with the steady progress of our pipeline, which included multiple filing acceptances in Europe and the ...

Read updates from clinical trials and scientific research on Huntington’s disease from Day 3 of the 2024 Huntington Study ...

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...

clinical trials and research and development programs; the unpredictable relationship between preclinical study results and clinical study results; delays in submission of regulatory filings or ...

Net income of $1.5 millionAdjusted EBITDA1 of $1.9 millionADHD Portfolio net revenue up 1% to $15.3 millionPediatric Portfolio net revenue up 54% sequentially$20.1 million cash balance at September 30 ...

In this week’s episode of “Podnosis,” we’re diving deep into the current landscape of clinical trials in the U.S.

Researchers from the Walter and Eliza Hall Institute (WEHI)in Australia have found a new way to predict a subset of patients ...

Marie Rahne, director, and Douglas Yee, MD, interim medical director of the Minnesota Cancer Clinical Trial Network spoke to Becker's about how their organization is broadening the scope of cancer ...

Machine learning and artificial intelligence wouldn't be possible without the statistical models that underpin their analytic ...

A decade-long effort has resulted in a new, rapid genomic test to diagnose rare infectious diseases in the brain and lungs.